A pharmacodynamic comparison of a personalized strategy for anti-platelet therapy versus ticagrelor in achieving a therapeutic window.
Malhotra N, Abunassar J, Wells GA, McPherson R, Fu A, Hibbert B, Labinaz M, Le May M, Dick A, Glover C, Froeschl M, Marquis JF, Tran L, Bernick J, Chong AY, So DY; CArdiovascular Percutaneous Intervention TriAL (CAPITAL) investigators.
Malhotra N, et al.
Int J Cardiol. 2015 Oct 15;197:318-25. doi: 10.1016/j.ijcard.2015.06.016. Epub 2015 Jun 15.
Int J Cardiol. 2015.
PMID: 26151596